Prostate cancer Posts on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Does age matter? Enzalutamide or bicalutamide for mestastatic castration-resistant prostate cancer patients of different ages

Posted by on Feb 12, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to examine the effectiveness and safety of enzalutamide (Xtandi) compared to bicalutamide (Casodex) in castration-resistant metastatic prostate cancer (cancer that does not respond to hormone therapy) patients in different age groups. This study concluded that enzalutamide improved outcomes for...

Read More

PSA response after cabazitaxel treatment is associated with improved progression-free survival in men with metastatic castration-resistant prostate cancer.

Posted by on Jan 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to examine the links between prostate specific antigen (PSA, a protein present in prostate cancer) and survival in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. This studty concluded that PSA response after cabazitaxel treatment is associated with improved...

Read More

What is Neutropenia?

What is Neutropenia?

Posted by on Jan 21, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...

Read More

Emergencies and Illness

Emergencies and Illness

Posted by on Jan 17, 2018 in Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Hodgkin's lymphoma, Hypertension, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 1 comment

After three hurricanes, flooding, fires and mudslides, and now severe cold and snow in the Deep South and throughout the country, the US has had its share of emergencies. Are you prepared? For people who rely on oxygen, who are on dialysis, have diabetes or other serious conditions, it is time to think about putting together some of the essentials.  What...

Read More

Abiraterone acetate and docetaxel with androgen deprivation therapy in high risk and metastatic hormone naive prostate cancer

Posted by on Jan 15, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to find out if androgen deprivation therapy (ADT) is more effective used with docetaxel (Taxotere) or abiraterone (Zytiga). There was no significant difference found between the two treatment options.  Some background Androgen deprivation therapy (ADT) is a treatment used for advanced prostate...

Read More

Peonies and Hope

Peonies and Hope

Posted by on Dec 23, 2017 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 2 comments

“People are like peonies, they need a good hard frost to bring out the character.” ~Francis “Doc” Winter “Doc” Winter was a Midwesterner.  Born in Iowa in 1931, in the midst of the Great Depression, he grew up on a small farm.  He knew about hard frosts. Struggle, pain and suffering are part of life.  Joy, love and...

Read More

Does metformin improve survival rates in patients with prostate cancer?

Posted by on Dec 22, 2017 in Prostate cancer | 0 comments

In a nutshell This study investigated if the use of metformin for anti-diabetic therapy improved survival rates in men also treated for prostate cancer. They found that patients taking metformin may have a greater chance of survival from prostate cancer. Some background Metformin is a medication that is commonly used to lower blood sugar levels...

Read More

Local treatment plus androgen deprivation therapy used as treatment for node-positive prostate cancer.

Posted by on Dec 17, 2017 in Prostate cancer | 0 comments

In a nutshell This study aims to find out if local treatment with or without ADT  is useful in the case of node-positive prostate cancer. This study found that local therapy and androgen deprivation therapy (ADT) is more effective for patients with node-positive prostate cancer than ADT alone.    Some background Local treatment or...

Read More